Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesNovocure Ltd

Novocure Ltd

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
11.99 USD 0.18 ( 1.52%)
Last update at 2026-11-11T21:26:00Z
VOLUME
1526473
Market Cap
2457.84M

Momentum Score

…

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
11.75
Low
12.41
High
52 Week Price Range
10.87
Low
82.64
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
11.81
Dividend Yield
-
Revenue TTM
525.66M
Revenue Per Share
4.92
Gross Profit TTM
423.58M
Debt / Equity
1.64
ROE
-48.70%
Net Debt
355.42M
ROCE
-10.36%
Diluted EPS TTM
-1.81

Stock Analysis

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -81.85M -52.08M 18.10M -8.82M -45.94M
Net income -92.53M -58.35M 19.81M -7.23M -63.56M
Selling general administrative 132.75M 126.13M 107.44M 87.95M 73.46M
Selling and marketing expenses 173.66M 137.06M 118.02M 96.67M 77.66M
Gross profit 422.97M 420.15M 387.87M 262.71M 168.02M
Reconciled depreciation 10.62M 10.25M 9.15M 8.46M 9.01M
Ebit -100.15M -54.58M 21.25M -9.37M -42.68M
Ebitda -89.52M -44.33M 30.40M -0.91M -33.67M
Depreciation and amortization 10.62M 10.25M 9.15M 8.46M 9.01M
Operating income -89.52M -44.33M 21.25M -0.91M -33.67M
Other operating expenses 627.36M 579.36M 463.96M 352.23M 281.74M
Interest expense 3.33M 3.44M 13.15M 13.72M 13.49M
Tax provision 10.69M 6.28M -1.71M -1.59M 17.62M
Interest income 10.96M 0.79M 1.79M 4.40M 2.65M
Net interest income 11.20M -3.71M -14.95M -7.48M -11.87M
Income tax expense 10.69M 6.28M -1.71M -1.59M 17.62M
Total revenue 537.84M 535.03M 494.37M 351.32M 248.07M
Total operating expenses 512.50M 464.49M 357.46M 263.63M 201.69M
Cost of revenue 114.87M 114.88M 106.50M 88.61M 80.05M
Total other income expense net 7.68M -7.74M -3.15M -7.91M -0.40M
Net income from continuing ops -92.53M -58.35M 19.81M -7.23M -63.56M
Net income applicable to common shares -92.53M -58.35M 19.81M -7.23M -63.56M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 1146.13M 1191.65M 1139.49M 1051.98M 479.45M
Other current assets 8.53M 6.70M 0.81M 11.50M 0.00M
Total liab 783.63M 750.48M 729.00M 575.46M 261.66M
Total stockholder equity 362.50M 441.17M 410.49M 476.53M 217.79M
Other current liab -16.22M -18.03M -17.76M 42.20M -0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -985.50M -778.46M -685.93M -631.08M -650.88M
Other liab - 7.36M 11.19M 17.65M 11.72M
Other assets - 11.16M 12.09M 10.91M 4.90M
Cash 240.82M 115.33M 208.80M 234.67M 177.32M
Total current liabilities 179.12M 158.78M 142.60M 113.61M 86.31M
Current deferred revenue 16.22M 18.03M 17.76M 17.77M 11.77M
Net debt 355.42M 468.94M 366.41M 209.52M -13.76M
Short term debt 84.72M 73.58M 70.00M - 37.61M
Short long term debt total 596.24M 584.27M 575.21M 444.20M 163.56M
Other stockholder equity 1353.47M 1222.06M 1099.59M 1111.43M 871.44M
Property plant equipment - 32.68M 53.88M 11.39M 34.60M
Total current assets 1034.41M 1111.53M 1073.53M 999.44M 439.95M
Net tangible assets - 441.17M 410.49M 476.53M 217.79M
Short term investments 669.79M 854.10M 728.90M 607.90M 148.77M
Net receivables 77.11M 112.22M 110.59M 117.94M 88.06M
Long term debt 568.82M 565.51M 562.22M 429.90M 149.42M
Inventory 38.15M 29.38M 24.43M 27.42M 23.70M
Accounts payable 94.39M 85.20M 72.60M 53.65M 36.92M
Accumulated other comprehensive income -5.47M -2.43M -3.17M -3.83M -2.77M
Retained earnings total equity - -778.46M -685.93M -631.08M -650.88M
Non currrent assets other 14.02M 11.16M 12.09M 10.91M 4.90M
Non current assets total 111.72M 80.12M 65.97M 52.54M 39.50M
Capital lease obligations 27.42M 18.76M 13.00M 14.29M 14.14M
Long term debt total - 565.51M 562.22M 429.90M 149.49M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -139.96M -120.66M -457.88M -41.18M 1.22M
Change to liabilities 4.27M 27.78M 26.13M 9.88M 23.22M
Total cashflows from investing activities -139.96M -144.83M -472.85M -51.67M -5.49M
Net borrowings -0.03M -0.03M 408.41M -0.03M 49.07M
Total cash from financing activities 15.49M 25.70M 440.21M 61.68M 69.37M
Change to operating activities -0.67M -6.46M -0.70M -3.56M 8.55M
Net income -92.53M -58.35M 19.81M -7.23M -63.56M
Change in cash -93.78M -36.56M 66.76M 36.66M 62.04M
Begin period cash flow 209.61M 246.17M 179.42M 142.76M 80.72M
End period cash flow 115.83M 209.61M 246.17M 179.42M 142.76M
Total cash from operating activities 30.79M 82.76M 99.15M 26.62M -1.86M
Issuance of capital stock 5.22M 4.55M 3.37M 2.47M 1.83M
Depreciation 10.62M 10.25M 9.15M 8.46M 9.01M
Other cashflows from investing activities - - - -41.18M -3.79M
Change to inventory -4.34M 2.48M -2.94M -1.16M -0.53M
Change to account receivables 2.55M 5.27M -30.35M -36.50M -4.15M
Sale purchase of stock 15.52M 25.73M 31.80M 61.71M 20.30M
Other cashflows from financing activities 10.29M 21.18M 586.87M 59.24M 167.62M
Change to netincome 104.65M 101.79M 75.45M 51.90M 40.25M
Capital expenditures 21.36M 24.17M 14.97M 10.48M 6.71M
Change receivables 2.55M 5.27M -30.35M -36.50M -4.15M
Cash flows other operating 7.11M 4.52M -1.37M 3.45M -7.12M
Cash and cash equivalents changes -93.68M -36.38M 66.51M 36.63M 62.01M
Change in working capital 11.80M 29.07M -8.52M -24.33M 11.41M
Stock based compensation 106.95M 94.90M 75.72M 52.42M 39.85M
Other non cash items -6.05M 3.01M 3.26M -2.17M 1.02M
Free cash flow 9.43M 58.59M 84.18M 16.14M -8.58M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NVCR
Novocure Ltd		 0.18
1.52%		 11.99 - 909.09 2.85 4.01 2.24 -6.42
ABT
Abbott Laboratories		 -1.17
1.06%		 109.29 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.02
0.02%		 101.61 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -5.50
1.70%		 318.79 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 0.30
0.63%		 48.57 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

No. 4 The Forum, Saint Helier, Jersey, JE2 4UF

44 15 3475 6700

https://www.novocure.com

1453

Name Title Year Born
Mr. William F. Doyle Exec. Chairman 1962
Mr. Asaf Danziger Pres, CEO & Director 1966
Ms. Ashley Cordova Chief Financial Officer 1980
Mr. Wilhelmus C. M. Groenhuysen Chief Operating Officer 1958
Mr. Pritesh Shah Chief Commercial Officer 1978
Prof. Yoram Palti M.D., Ph.D. Founder & CTO 1938
Mr. Uri Weinberg M.D., Ph.D. Chief Science Officer NA
Ms. Ingrid Goldberg VP of Investor Relations NA
Mr. Barak Ben Arye Gen. Counsel NA
Mr. William Patrick Burke Chief HR Officer 1955

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…